梅州白带有血是什么情况(梅州附件炎的诊断方法) (今日更新中)

BEIJING, Dec. 7 (Xinhua) -- The Chinese government on Wednesday released a white paper on its foreign trade, highlighting the country's achievements in boosting foreign trade and contribution to the world economy.The white paper, titled China's Foreign Trade, was released by the Information Office of the State Council.The white paper introduces China's historic progress, international contribution and policies in foreign trade.

WASHINGTON, Oct. 13 (Xinhua) -- U.S. researchers have corrected sickle cell disease in adult laboratory mice that had been bred to have the inherited blood disorder by activating production of a special blood component, according to a study published online Thursday in the journal Science.Sickle cell disease results from an abnormality in hemoglobin, the protein found in red blood cells that is responsible for transporting oxygen throughout the body. People living with sickle cell disease have two copies of an altered gene that produces sickle hemoglobin instead of normal adult hemoglobin. Sickle hemoglobin changes shape after releasing its oxygen, causing the red blood cell to become stiff, misshapen and sticky, and slowing blood flow to tissues. This process damages organs and causes pain.The study tested a new approach to increasing the production of a third form of hemoglobin -- fetal hemoglobin. Production of fetal hemoglobin predominates before birth, but turns off thereafter as adult hemoglobin production takes over. People with sickle cell disease are unable to make normal adult hemoglobin, and instead make sickle hemoglobin starting in infancy.An elevated level of fetal hemoglobin within the red blood cell reduces the tendency of sickle hemoglobin to change the shape of red blood cells. Considerable research has shown that the drug hydroxyurea increases production of fetal hemoglobin and reduces the number of pain crises and other complications of sickle cell disease in adults and children. However, not all patients respond well to hydroxyurea, and adverse side effects are a concern.The current study explores a more targeted approach to increasing fetal hemoglobin production. It builds upon earlier studies that discovered a protein called BCL11A normally suppresses the production of fetal hemoglobin soon after birth. The researchers viewed the BCL11A protein as a target for therapy and decided to see what would happen if they blocked production of the protein.The paper details how the research team silenced the mouse gene that produces the BCL11A protein in mice with sickle cell disease. Silencing the gene turned off production of the BCL11A protein and allowed the adult mice to continue to produce fetal hemoglobin. It appears to have eliminated disease symptoms without affecting other aspects of blood production."This discovery provides an important new target for future therapies in people with sickle cell disease," said Susan Shurin, acting director of the U.S. National Heart, Lung, and Blood Institute, which co-funded the study. "More work is needed before it will be possible to test such therapies in people, but this study demonstrates that the approach works in principle."Approximately 100,000 Americans live with sickle cell disease. It is most prevalent in people of African, Hispanic, Mediterranean, and Middle Eastern descent. There is no widely available cure for sickle cell disease. Bone marrow transplants have cured some patients, but the treatment is not without risk and most patients do not have relatives who can donate compatible and healthy bone marrow to them.

SAN FRANCISCO, Dec. 9 (Xinhua) -- Hewlett-Packard (HP) on Friday announced that it is keeping the webOS software alive by contributing it to the open source community.The company said it will make the underlying code of webOS available under an open source license and will engage the open source community to help define the charter of the open source project."WebOS is the only platform designed from the ground up to be mobile, cloud-connected and scalable," Meg Whitman, HP's chief executive officer, said in a statement."By contributing this innovation, HP unleashes the creativity of the open source community to advance a new generation of applications and devices," she added.HP said it will remain active in the development and support of webOS, while the source code will be available for use and improvement by anyone choosing to download it, which means other hardware manufacturers can also use the software.With the help of the open source community, HP can save development and other costs and the new announcement is expected to result in more layoffs from its webOS team, some analysts noted.The webOS is a mobile operating system initially developed by Palm which was acquired by HP last April for 1.2 billion U.S. dollars.In February this year, HP released TouchPad, its first tablet computer which runs the webOS operating system. The device didn't sell well, and HP in August decided to completely shut down webOS hardware business, including TouchPad and webOS phones.HP then said that it will continue to explore options to optimize the value of webOS software going forward.By keeping the software open source, users of webOS devices will continue to receive software improvements and updates in the future, HP noted."As webOS gains traction as an open source alternative in the marketplace, you could see webOS on several different types of devices by any number of vendors. We will explore the viability of putting webOS on devices, just as we do for other leading operating systems," the company said in a corporate blog post.

SUVA, Jan. 21 (Xinhua) -- Three in four people of the Fiji population are physically inactive causing an increase in health risks, says the country's Ministry of Health.National Advisor on Non-Communicable Disease Dr. Isimeli Tukana said that lifestyle in this Fijian generation has changed a lot, especially for the younger population that have been influenced by technology.Tukana said on Friday many children nowadays are obese and that was of growing concern. That is why the Ministry of Health is working with the Ministry of Education in promoting more physical education in schools and making it compulsory from this school term.Fiji was recently ranked the fourth-most obese nation in the region, according to the Health Ministry.Recent studies in Fiji showed a high incidence of anaemia in children, women and men.Figures released by the ministry said more than 60 percent of the island nation's population is overweight while a significant number are deficient in iron and micronutrients.The figures show that the high rate of premature disability with Non Communicable Diseases (NCD), infection and cancer has taken its toll on the population."The importance of our traditional diets, healthy eating and physical activities is paramount," a ministry statement had said."In the Pacific NCDs have reached epidemic proportions," it said."Nutritional imbalances resulting from not eating local produce instead of canned, processed food contribute to the equation, especially in these times of global economic crisis."Women's Minister Dr. Jiko Luveni has advised mothers in the country this week to stock up on healthy foods for their families.She said having green leafy vegetables was vital and buying fruits for children's snacks instead of salted prepacked ones was the way to keep the family healthy.The National Food and Nutrition Council said Friday that as the school year draws parents should find healthy alternatives for their children.They have urged teachers and parents to include fruits in every child's meal to reduce NCDs.In other countries in the region Tokelau and Nauru's obesity rates stand at 93 percent to 93.5 percent of the population.In American Samoa and Kiribati obesity stands at 81.5 percent of the population, while Marshall Islands at 80.1 percent, Federated States of Micronesia (Pohnpei) at 73.1 percent.

BEIJING, Dec. 10 (Xinhua) -- Pharmaceutical producers will risk having their operation license revoked if they use prohibited chemicals as medicine ingredients or involved in fake drug production, China's drug regulator said in a circular Saturday.The State Food and Drug Administration said it would name and shame pharmaceutical companies if they make phoney medicine and withdraw the operation licenses of pharmacies if they intentionally sell unqualified drugs.The circular came in the wake of several counterfeit medicine scandals uncovered by Chinese police in the past few months.On Nov. 4, police seized more than 65 million imitation medicinal tablets and arrested 114 suspects in a cross-provincial raid on counterfeit drugs.In October, police raided on an illegal drug production and sale network and ended up with the seizure of 190 million yuan (29.9 million U.S. dollars) worth of counterfeit drugs.The suspects were found to have used starch or corn powder as ingredients for bogus medicine, or re-packaged expired pharmaceuticals.Police also found animal feed and chemical pigments in the counterfeit products.

来源：资阳报